Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.
about
γδ T Cell Immunotherapy-A ReviewEfficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging.Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation.Effect of zoledronate on the responses of osteocytes to acute parathyroid hormone.Osteoporosis treatment: why ibandronic acid?Osteogenesis imperfecta: diagnosis and treatment.The use of bisphosphonates in women: when to use and when to stop.Safety issues and adverse reactions with osteoporosis management.Immune cell profile of dental pulp tissue treated with zoledronic acid.The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid.Surgical trauma and low-dose methylprednisolone modulate the severity of the acute-phase response induced by zoledronic acid infusion.Acute phase response after zoledronic acid is associated with long-term effects on white blood cells.Markers of inflammation after zoledronic acid redosing.Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.Could γ/δ T Cells Explain Adverse Effects of Zoledronic Acid? Comment on the Article by Reinhardt et al.Cytokines and insulin resistance after zoledronic acid-induced acute phase response.Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T Cells
P2860
Q26995102-EAEA8ED2-AD03-42E5-82BC-7257AE36912CQ35109433-63A04068-AB86-4A98-B958-D7B072C4304AQ36299558-CF0B1462-F63F-491F-8F65-7F0CB8153782Q36849984-5B145623-4C71-4DD8-A9D3-8111743CC2C9Q38104738-22D3DA6F-8ABA-471E-8071-49BBE918FAD9Q38223208-91D7E96C-EAAF-4EF9-8847-53BF339EB9BBQ38584336-A3313C2A-D60E-4959-A3E2-53422072AED2Q38677822-85E8566E-5879-4920-B6F0-9AF80E0860B4Q39098260-3F5B43C3-DC43-41C1-8063-B9FB639E2597Q40052962-D9DFAA58-F7FB-479A-A4BD-0537F6258B1CQ41115341-61A055C8-31A7-44C5-882C-43BAD613BC2FQ45731159-802BCD68-97CD-4BDD-A43A-1F1BBC9459B8Q46204282-2078D9AD-5210-4830-8831-174D51838F70Q50932570-32FB60FF-D924-4AF9-987A-C33B03AA832DQ53962822-91B585B7-7FB8-4172-B685-B536988B6C6AQ54297545-1BB6258D-61A1-4EFD-A55D-1C4F0743E485Q58903536-BA4758BB-AE69-4713-B547-542205AE4CC7
P2860
Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Circulating γδ T cells and the ...... oledronic acid administration.
@en
type
label
Circulating γδ T cells and the ...... oledronic acid administration.
@en
prefLabel
Circulating γδ T cells and the ...... oledronic acid administration.
@en
P2093
P2860
P356
P1476
Circulating γδ T cells and the ...... zoledronic acid administration
@en
P2093
Antonio Vella
Elena Fracassi
Ombretta Viapiana
Riccardo Ortolani
Silvano Adami
P2860
P304
P356
10.1002/JBMR.521
P577
2012-01-01T00:00:00Z